IHI Corporation
IHI Corporation (IHICY) Financial Performance & Income Statement Overview
Analyze IHI Corporation (IHICY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
IHI Corporation (IHICY) Income Statement & Financial Overview
Review IHI Corporation IHICY income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $476.84B | $392.50B | $409.32B | $348.16B |
| Cost of Revenue | $372.83B | $305.78B | $300.36B | $273.36B |
| Gross Profit | $104.02B | $86.72B | $108.97B | $74.81B |
| Gross Profit Ratio | $0.22 | $0.22 | $0.27 | $0.21 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $60.95B | $59.70B | $52.03B | $50.96B |
| Operating Expenses | $60.95B | $60.52B | $52.03B | $50.98B |
| Total Costs & Expenses | $433.78B | $366.30B | $352.38B | $324.33B |
| Interest Income | $0.00 | $10.67B | $0.00 | $8.97B |
| Interest Expense | $7.49B | $0.00 | $18.02B | $3.43B |
| Depreciation & Amortization | $23.66B | $18.05B | $17.74B | $17.32B |
| EBITDA | $54.37B | $44.25B | $71.17B | $41.15B |
| EBITDA Ratio | $0.11 | $0.11 | $0.17 | $0.12 |
| Operating Income | $43.06B | $26.20B | $56.94B | $23.83B |
| Operating Income Ratio | $0.09 | $0.07 | $0.14 | $0.07 |
| Other Income/Expenses (Net) | -$19.84B | $24.56B | -$28.09B | $7.85B |
| Income Before Tax | $23.22B | $50.76B | $28.85B | $31.68B |
| Income Before Tax Ratio | $0.05 | $0.13 | $0.07 | $0.09 |
| Income Tax Expense | -$13.57B | $13.05B | $9.78B | $11.93B |
| Net Income | $35.95B | $37.48B | $20.73B | $18.58B |
| Net Income Ratio | $0.08 | $0.10 | $0.05 | $0.05 |
| EPS | $237.51 | $247.60 | $136.93 | $122.77 |
| Diluted EPS | $237.51 | $247.60 | $136.93 | $122.77 |
| Weighted Avg Shares Outstanding | $151.36M | $151.38M | $151.36M | $151.36M |
| Weighted Avg Shares Outstanding (Diluted) | $151.36M | $151.38M | $151.36M | $151.36M |
Over the last four quarters, IHI Corporation's revenue moved from $348.16B in Q1 2024 to $476.84B in Q4 2024. Operating income in Q4 2024 was $43.06B, with a strong operating margin of 9%. Despite fluctuations in R&D and SG&A expenses, EBITDA for IHI Corporation remained robust at $54.37B, reflecting operational efficiency. Net income dropped to $35.95B, with an EPS of $237.51. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan